TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome
Status:
Completed
Trial end date:
2019-04-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the cutaneous toxicity and treatment response
associated with administering concurrent TSEB and brentuximab vedotin in patients with
mycosis fungoides or Sézary Syndrome.